Medpace Holdings (MEDP) Deferred Taxes (2015 - 2026)
Medpace Holdings' (MEDP) quarterly Deferred Taxes came in at $4.3 million in Q2 2026, down 87.45% on a YoY basis from $34.1 million in Q2 2025, and down 76.91% quarter-over-quarter from $18.5 million in Q1 2026.
Analysis
Medpace Holdings (MEDP) Deferred Taxes (2015 - 2026) Analysis & Trends
Medpace Holdings (MEDP) has reported Deferred Taxes for 12 consecutive years, with $4.3 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Deferred Taxes fell 87.45% year-over-year to $4.3 million; the trailing twelve-month figure through Jun 2026 stood at $68.7 million (up 651.84% YoY), and the FY2025 full-year result was $80.8 million, up 403.29% from the prior year.
- Deferred Taxes retreated to $4.3 million in Q2 2026 per MEDP's latest filing, from $18.5 million in the prior quarter.
- Across five years, Deferred Taxes topped out at $34.1 million in Q2 2025 and bottomed at -$24.2 million in Q4 2024.
- Historically, Deferred Taxes has averaged $1.6 million across 5 years, with a median of -$719500.0 in 2022.
- The sharpest annual moves came in 2023 and 2025: Deferred Taxes sank 1006.11% in 2023, then surged 63261.11% in 2025.
- Over 5 years, Deferred Taxes stood at -$20.9 million in 2022, then surged by 33.89% to -$13.8 million in 2023, then sank by 75.24% to -$24.2 million in 2024, then soared by 171.93% to $17.4 million in 2025, then slumped by 75.41% to $4.3 million in 2026.
- According to Business Quant data, Deferred Taxes over the past three periods registered $4.3 million, $18.5 million, and $17.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | -36.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 4.28 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | -3.28 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 41.49 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 4.90 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | - |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | - |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | - |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.28 Mn |
| Mar 31, 2026 | 18.54 Mn |
| Dec 31, 2025 | 17.41 Mn |
| Sep 30, 2025 | 28.51 Mn |
| Jun 30, 2025 | 34.11 Mn |
| Mar 31, 2025 | 749,000.00 |
| Dec 31, 2024 | -24.20 Mn |
| Sep 30, 2024 | -1.51 Mn |
| Jun 30, 2024 | -54,000.00 |
| Mar 31, 2024 | -865,000.00 |
| Dec 31, 2023 | -13.81 Mn |
| Sep 30, 2023 | -7.60 Mn |
| Jun 30, 2023 | -2.65 Mn |
| Mar 31, 2023 | -1.06 Mn |
| Dec 31, 2022 | -20.89 Mn |
| Sep 30, 2022 | -687,000.00 |
| Jun 30, 2022 | -726,000.00 |
| Mar 31, 2022 | -713,000.00 |
| Dec 31, 2021 | -40.41 Mn |
| Sep 30, 2021 | 632,000.00 |